Should I buy L3Harris (LHX) stock or is it too late?
⭐ The most reliable of them, either direction: Guggenheim — 82% of its targets hit on this sector (27 calls tested). It aims for $365 (+56 %), call made on September 16, 2026, maturing on September 16, 2027 (28 d ago).
Firm-by-firm track record on L3Harris
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Truist Securities | 92 % | +29.9 % | 12 | $353 +50% |
| Citigroup | 89 % | +26.4 % | 9 | $418 +78% |
| Wells Fargo | 85 % | +24.2 % | 13 | $242 +3% |
| JP Morgan | 80 % | +21.4 % | 5 | $395 +68% |
| RBC Capital | 91 % | +12.4 % | 11 | $365 +56% |
| Susquehanna | 75 % | +10.9 % | 8 | $350 +49% |
| Morgan Stanley | 67 % | +9.3 % | 9 | $390 +66% |
| Baird | 40 % | -0.0 % | 5 | $320 +36% |
✅ Reasons to believe
- 71% of analysts rate it a buy (Buy consensus, 7 ratings) — a sign of market conviction.
- Median price target $346, i.e. +47% from the current price ($235).
- The most reliable firm on LHX, Goldman Sachs (100% hit rate, 2 scored calls), targets $361 (call made on October 12, 2026, maturing on October 12, 2027) (+54%) in its most recent call.
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (1.7% yield), raised for 21 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 7 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on LHX
Median target $346 (+47%) · 7 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in L3Harris now?
We won't decide for you. The facts: 71% of analysts rate it a buy, median target $346 (+47%), and Goldman Sachs (most reliable on LHX, 100%) targets $361. Weigh that against valuation (P/E ~24). This is not personalized advice.
Is it too late to invest in L3Harris?
Not according to analysts: the median target ($346) is still +47% above the current price ($235) (most reliable on LHX: Goldman Sachs, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is L3Harris still worth investing in?
It depends on the gap between the price ($235) and its estimated value: analysts target $346 on median (+47%), with 71% buys (most reliable on LHX: Goldman Sachs, 100%). Cross-check with their real reliability on LHX and the cautions above. Information, not advice.
What's the main risk in buying LHX?
The consensus is not unanimous: of 7 ratings, 2 are neutral.
→ Go deeper: the full L3Harris profile (consensus, analyst reliability, price target, performance).